Reciprocal Activity of Ginsenosides in the Production of Proinflammatory Repertoire, and their Potential Roles in Neuroprotection in vitro

Abstract

Ginsenosides, the active compounds inherent to most Ginseng species [e. g., Panax ginseng (Araliaceae)], have recently been the focus of increased attention, due to both their purported CNS, antineoplastic and immunomodulatory effects, and their ability to stimulate phagocytosis. In this study, we attempted to determine the effects of ginsenosides Rb1 and Rg1 in a rat model, with specific emphasis on nitric oxide and cytokines, which have been implicated in chronic brain inflammation. We discovered that Rb1 and Rg1 exert opposite effects in a dose-dependent manner (50 - 250 μg/mL). Whereas Rg1 stimulated nitric oxide and proinflammatory cytokines (IL-1β, IL-6, and TNF-α), Rb1 exerted a significant inhibitory effect on this proinflammatory repertoire. In addition, the genetic expression of bcl-2 and bax, both of which have been implicated in apoptosis, was regulated by treatment with Rb1 and Rg1, at a concentration of 250 μg/mL. Moreover, when combined treatment with equal doses of Rb1 and Rg1 was given, Rb1 significantly counteracted the stimulatory effects of Rg1, as evidenced by an NO assay. This effect persisted stably for 72 h. In conclusion, neurodegenerative diseases such as Alzheimer’s disease, which is caused primarily by cell death due to chronic inflammation and cell stress, might be controlled by proper doses of non-toxic, natural Rg1 and Rb1.

Ginsenosides - Panax ginseng - Araliaceae - Rg1 - Rb1 - nitric oxide - IL-1β - IL-6 - TNF-α

References

• 1 Iqbal K. Prevalence and neurobiology of Alzheimer disease: some highlights. In: Iqbal K, McLachlan DRC, Winblad B, Wisniewski HM (Eds.) Alzheimer’s Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies. Wiley-Interscience Chichester; 1991: pp 9-12
• 2 Anderson R N, Arias E. The effect of revised populations on mortality statistics for the United States, 2000. National Vital Statistics Reports 2003 51(9)
• 3 Rossor M. Disorders of psychic function. Dementia. In: Asbury AK, McKhann GM, McDonald WI (Eds.) Disease of the Nervous System: Clinical Neurobiology. 2nd edition WB Saunders Company Philadelphia; 1992: pp 788-94
• 4 McGuire S O, Ling Z D, Lipton J W, Sortwell C E, Collier T J, Carvey P M. Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons.  Exp Neurol. 2001;  169 219-30
• 5 Rogers J, Luber-Narod J, Styren S D, Civin W H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer’s disease.  Neurobiol Aging. 1988;  9 339-49
• 6 Kim S H, Lah J J, Thinakaran G, Levey A, Sisodia S S. Subcellular localization of presenilin: association with a unique membrane pool in cultured cells.  Neurobiol Dis. 2000;  7 99-117
• 7 Paresce D M, Chung H, Maxfield F R. Slow degradation of aggregates of the Alzheimer’s disease amyloid beta-protein by microglial cell.  J Biol Chem. 1997;  272 29 390-7
• 8 McGeer P L, McGeer E G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases.  Brain Res Rev. 1995;  21 195-218
• 9 Shibata S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds.  J Korean Med Sci. 2001;  16 S28-37
• 10 Rivest S. Molecular insights on the cerebral innate immune system.  Brain Behavior and Immunity. 2003;  17 13-9
• 11 Paresce D M, Chung H, Maxfield F R. Slow degradation of aggregates of the Alzheimer’s disease amyloid beta-protein by microglial cells.  J Biol Chem. 1997;  272 29 390-7
• 12 Xie Z, Morgan T E, Rozovsky I, Finch C E. Aging and glial responses to lipopolysaccharide in vitro: greater induction of IL-1 and IL-6, but smaller induction of neurotoxicity.  Exp Neurol. 2003;  182 135-41
• 13 Lue L, Rydel R, Brigham E F, Yang L, Hampek H, Murphy G M. et al . Inflammatory repertoire of Alzheimer’s disease and non demented elderly microglia in vitro .  Glia. 2001;  35 72-9
• 14 Selkoe D J. Alzheimer’s disease: genes, proteins, and therapy.  Physiol Rev. 2001;  81(2) 741-66
• 15 Gregersen R, Lambertsen K, Finsen B. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice.  J Cereb Blood Flow Metab. 2000;  20 53-65
• 16 Aloisi F, Ria F, Adorini L. Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes.  Immunol Today. 2000;  21 141-7
• 17 Frei K, Malipiero U V, Leist T P, Zinkernagel R M, Schwab M E, Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases.  Eur J Immunol. 1989;  19 689-94
• 18 Tarkowski E, Blennow K, Wallin A, Tarkowski A. Intracerebral production of TNF-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia.  J Clin Immun. 1999;  19 223-30
• 19 Rath P C, Aggarwal B B. TNF-induced signaling in apoptosis.  J Clin Immunol. 1999;  19 350-64
• 20 Combs C K, Karlo J C, Kao S -C, Landreth G E. Beta-amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.  J Neurosci. 2001;  21 1179-88
• 21 Rogers J T, Leiter L M, McPhee J, Cahill C M, Zhan S S, Potter H. et al . Translation of the Alzheimer amyloid precursor protein mRNA is upregulated by interleukin-1 through 5′-untranslated region sequences.  J Biol Chem. 1999;  274 6421-31
• 22 Strauss S, Bauer J, Ganter U, Jonas U, Berger M, Volk B. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer’s disease patients.  Lab Invest. 1992;  66 223-30
• 23 Wisniewski H M, Vorbrodt A W, Wegiel J, Morys J, Lossinsky A S. Ultrastructure of the cells forming amyloid fibers in Alzheimer disease and scrapie.  Am J Med Genet. 1990;  7 287-97
• 24 Feuerstein G Z, Wang X, Barone F C. The role of cytokines in the neuropathology of stroke and neurotrauma.  Neuroimmunomodulat. 1998;  5 143-59